Bisaryl-bonded aryltriazolones and use thereof

US9687476B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Chantal Fürstner · Neheim, DE
• Jörg Keldenich · Wuppertal, DE
• Martina Delbeck · Essen, DE
• Peter Kolkhof · Wuppertal, DE
• Axel Kretschmer · Wuppertal, DE
• Ingo Pluschkell · Bochum, DE
• Elisabeth Pook · Wuppertal, DE
• Carsten Schmeck · Wuppertal, DE
• Hubert Trübel · Wuppertal, DE

Key dates

• Filing date: Nov 2, 2015
• Grant date: Jun 27, 2017
• Expiry date: Nov 2, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel bisaryl-linked 5-aryl-1,2,4-triazolone derivatives, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.